HIF-1α Promotes Hepatocellular Carcinoma Metastasis by Regulating Angiogenesis and Epithelial-Mesenchymal Transition
暂无分享,去创建一个
Wei Wu | Xiyu Chen | Ying Chen | Li Wang | M. Yao | Defeng Wang | Jie-ke Yang | Dengfu Yao
[1] Gao-lin Liu,et al. Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling , 2020, BMC Cancer.
[2] K. Mortezaee. Hypoxia induces core-to-edge transition of progressive tumoral cells: A critical review on differential yet corroborative roles for HIF-1α and HIF-2α. , 2019, Life sciences.
[3] I. Berindan‐Neagoe,et al. Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes , 2019, International journal of molecular sciences.
[4] A. Vogel,et al. Current strategies for the treatment of intermediate and advanced hepatocellular carcinoma. , 2019, Cancer treatment reviews.
[5] Qiang Wang,et al. 6-C-(E-phenylethenyl)naringenin attenuates the stemness of hepatocellular carcinoma cells by suppressing Wnt/β-catenin signaling. , 2019, Journal of agricultural and food chemistry.
[6] Quanzhou Peng,et al. HIF-1-miR-219-SMC4 Regulatory Pathway Promoting Proliferation and Migration of HCC under Hypoxic Condition , 2019, BioMed research international.
[7] Z. Dong,et al. Oncogenic Wnt3a: A Candidate Specific Marker and Novel Molecular Target for Hepatocellular Carcinoma , 2019, Journal of Cancer.
[8] Hui Guo,et al. Epithelial–mesenchymal transition induced cancer‐stem‐cell‐like characteristics in hepatocellular carcinoma , 2019, Journal of cellular physiology.
[9] Zuqing Su,et al. Basil polysaccharide inhibits hypoxia-induced hepatocellular carcinoma metastasis and progression through suppression of HIF-1α-mediated epithelial-mesenchymal transition. , 2019, International journal of biological macromolecules.
[10] Ming Yan,et al. Dual functions of STAT3 in LPS-induced angiogenesis of hepatocellular carcinoma. , 2019, Biochimica et biophysica acta. Molecular cell research.
[11] Z. Dong,et al. Alteration of oncogenic IGF-II gene methylation status associates with hepatocyte malignant transformation. , 2019, Hepatobiliary & pancreatic diseases international : HBPD INT.
[12] 松浦 雄祐. Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells , 2019 .
[13] K. Shailubhai,et al. Hepatocellular Carcinoma: Etiology and Current and Future Drugs. , 2019, Journal of clinical and experimental hepatology.
[14] Liang Han,et al. Curcumin Suppresses Hepatic Stellate Cell-Induced Hepatocarcinoma Angiogenesis and Invasion through Downregulating CTGF , 2019, Oxidative medicine and cellular longevity.
[15] Dan Wang,et al. Hypoxia inducible factor 1α in hepatocellular carcinoma with cirrhosis: Association with prognosis. , 2018, Pathology, research and practice.
[16] Y. Takeda,et al. Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells , 2018, Digestive Diseases and Sciences.
[17] Jia-chu Li,et al. Krüppel-like factor 8 regulates VEGFA expression and angiogenesis in hepatocellular carcinoma , 2018, Scientific Reports.
[18] M. Mayer,et al. Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma , 2018, Oncogene.
[19] R. Weinberg,et al. New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer , 2018, Nature reviews. Molecular cell biology.
[20] J. González‐Gallego,et al. Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors , 2018, Experimental & Molecular Medicine.
[21] R. Finn,et al. The Role of Angiogenesis in Hepatocellular Carcinoma , 2018, Clinical Cancer Research.
[22] Hong-wei Lei,et al. Rapamycin Combi with TAE on the Growth, Metastasis, and Prognosis of Hepatocellular Carcinoma in Rat Models. , 2018, Annals of hepatology.
[23] M. Petrillo,et al. Hypoxia and tumor angiogenesis in the era of hepatocellular carcinoma transarterial loco-regional treatments. , 2018, Future oncology.
[24] Linxi Chen,et al. deSUMOylation signaling: a novel mechanism of liver CSC properties and hepatocarcinogenesis in hypoxia , 2017, Acta biochimica et biophysica Sinica.
[25] Yi-xin Zhang,et al. Cancer survival in Qidong between 1972 and 2011: A population-based analysis. , 2017, Molecular and clinical oncology.
[26] Baocun Sun,et al. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment , 2017, Journal of experimental & clinical cancer research : CR.
[27] Tao Lou,et al. Hypoxia inducible factors in hepatocellular carcinoma , 2017, Oncotarget.
[28] B. Luo,et al. Effect of a hypoxic microenvironment after radiofrequency ablation on residual hepatocellular cell migration and invasion , 2017, Cancer science.
[29] I. Ng,et al. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop , 2017, Gut.
[30] P. Hu,et al. LHBs can elevate the expression of MDR1 through HIF-1α in patients with CHB infection: a comparative proteomic study , 2016, Oncotarget.
[31] Yong Xie,et al. AEG-1 is associated with hypoxia-induced hepatocellular carcinoma chemoresistance via regulating PI3K/AKT/HIF-1alpha/MDR-1 pathway , 2016, EXCLI journal.
[32] Xiao-Ming Zhang,et al. The Changes of HIF-1α and VEGF Expression After TACE in Patients With Hepatocellular Carcinoma , 2016, Journal of clinical medicine research.
[33] Jennifer Wu,et al. Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target. , 2015, World journal of gastroenterology.
[34] Shan Li,et al. Association between hypoxia-inducible factor-1α gene polymorphisms and risk of chronic hepatitis B and hepatitis B virus-related liver cirrhosis in a Chinese population: a retrospective case-control study. , 2015, Gene.
[35] Brian Keith,et al. HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression , 2011, Nature Reviews Cancer.
[36] Q. Ni,et al. Expression Characteristics of Hypoxia-Inducible Factor-1α and Its Clinical Values in Diagnosis and Prognosis of Hepatocellular Carcinoma , 2011, Hepatitis monthly.
[37] K. Nan,et al. Activation of PI3 kinase/Akt/HIF-1α pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma. , 2011, International journal of oncology.
[38] Wei Wu,et al. Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma. , 2009, Hepatobiliary & pancreatic diseases international : HBPD INT.
[39] Jian-Li Hu,et al. Hepatitis B virus X protein and hypoxia‑inducible factor-1α stimulate Notch gene expression in liver cancer cells. , 2017, Oncology reports.
[40] D. Yao,et al. Abnormal expression of hepatoma specific gamma-glutamyl transferase and alteration of gamma-glutamyl transferase gene methylation status in patients with hepatocellular carcinoma. , 2000, Cancer.